Eloquest Healthcare: Creates an educational funding opportunity at the University of Wisconsin Hospital and Clinics

Contact: Jackie Schatell, 201-618-7444, jschatell@harkavygoldman.com

Ferndale, Michigan/Madison, Wisconsin – Eloquest Healthcare, a specialty company that focuses on improving dermal outcomes in the acute care market, is proud to announce that it has made a $1,000.00 donation to the University of Wisconsin Hospital and Clinic’s (UWHCf ) to help fund educational opportunities for advanced practice nurses.

“Advanced practice nurses play a crucial and expanding role in caring for our patients in both hospital and clinic settings. We are very grateful for this gift to support opportunities for their continuing education and development,” says Maureen P. McCausland, DNSc, RN, FAAN, senior vice president for Patient Care Services and chief nursing officer.

“Since the launch of Eloquest Healthcare in 2008, our company has been working with our customers to pursue a common goal of delivering excellence and compassion in healthcare,” says Tim O’Halla, vice president and chief operating officer, Eloquest Healthcare.

O’Halla adds, “In the pursuit to support nurses in their ongoing educational needs, we hope that our industry colleagues will join us in our healthcaring mission to provide them with these types of opportunities.”

University of Wisconsin Hospital and Clinics in Madison, Wisconsin, is a 536-bed facility that ranks among the finest academic medical centers in the United States. Frequently cited in publications listing the best health care providers, UW Hospital and Clinics is recognized as a national leader in fields such as cancer treatment, pediatrics, ophthalmology, surgical specialties and organ transplantation.

Eloquest Healthcare, Inc., the Healthcaring Company, headquartered in Ferndale, Michigan, was launched as a wholly-owned subsidiary of the Ferndale Pharma Group, Inc. in February 2008. Eloquest Healthcare, Inc. is focused specifically on serving acute care providers, their healthcare practitioners, and their patients. Eloquest Healthcare provides value to hospitals through products and services, which help improve dermal outcomes by minimizing dermal pain, preserving the integrity of the skin, and ensuring the integrity of devices adhesion to the skin. For more information, please visit the company’s website at: http://www.eloquesthealthcare.com.

The Eloquest Healthcare product portfolio includes:

* Mastisol® Liquid Adhesive

* Detachol® Adhesive Remover

* L.M.X.4® (lidocaine 4%) Topical Anesthetic Cream